PUBLISHER: Grand View Research | PRODUCT CODE: 2132493
PUBLISHER: Grand View Research | PRODUCT CODE: 2132493
The global anti-reflux valve market size was valued at USD 1.2 billion in 2025 and is projected to grow from USD 1.3 billion in 2026 to USD 2.4 billion by 2033, at a CAGR of 9.2% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 37.4% in 2025. The market growth is driven by the rising adoption of enteral feeding systems, increasing prevalence of chronic diseases requiring long-term nutritional support, growing geriatric population, and the expansion of home healthcare services.
In addition, the increasing prevalence of chronic diseases requiring long-term nutritional support is a significant driver of the anti-reflux valve industry. Conditions such as stroke, cancer, neurological disorders, chronic kidney disease, and gastrointestinal diseases often impair swallowing or gastrointestinal function, increasing the need for long-term enteral feeding and fluid management. Anti-reflux valves play a critical role in preventing backflow and contamination during enteral nutrition, thereby improving patient safety. For instance, in September 2025, according to the World Health Organization (WHO), noncommunicable diseases (NCDs) caused at least 43 million deaths globally, accounting for 75% of all non-pandemic-related deaths. Cardiovascular diseases accounted for approximately 19 million deaths, cancers for 10 million, chronic respiratory diseases for 4 million, and diabetes for over 2 million deaths. The growing burden of these chronic conditions is increasing the number of patients requiring long-term nutritional support, creating sustained demand for anti-reflux valve technologies.
The expanding hospital infrastructure is a key factor supporting the market growth, as hospitals represent major end users for enteral feeding systems, urinary drainage systems, infusion therapy devices, and catheter-based medical applications. Increasing patient admissions, rising demand for long-term care solutions, and a growing emphasis on infection prevention are driving healthcare providers to adopt medical devices equipped with reliable backflow-prevention mechanisms. Anti-reflux valves are integrated into catheter-associated systems, including urinary catheters, central venous access devices, and drainage systems, to help prevent fluid reflux, reduce contamination risks, and improve patient safety. The availability of a large network of hospitals and specialized care facilities creates a strong demand base for anti-reflux valve technologies across acute care, critical care, and long-term healthcare settings, as highlighted in the table below.
Global Anti-Reflux Valve Market Report Segmentation
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global anti-reflux valve market report based on application, material, usage, end use, and region: